Ophthalmology Devices Global Market - Forecast To 2021

  • ID: 3300499
  • Report
  • Region: Global
  • 328 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Carl Zeiss AG
  • Essilor International
  • Haag-Streit holdings AG
  • Hoya corporation
  • Johnson & Johnson
  • MORE
Ophthalmology is a segment of medical science associated with study of anatomy, physiology, diseases of human eye, and developing various therapeutic methods to treat eye diseases. Some of the major eye diseases are either age-related or caused due to chronic disorders. They
include various degenerative eye diseases like macular degeneration, cataract, ocular hypertension (glaucoma), and refractive errors among others. Revolution in the field of medical science has led to the rapid development of ophthalmology devices that are invented to effectively treat ocular defects and disorders.

The global ophthalmology devices market is expected to grow at a CAGR of around XX% from 2015 to 2021. Increasing incidence of degenerative diseases of eyes, increasing baby boomer population, increase in R&D activities in ophthalmology key players and extensive use of high-end technologies involving use of software and computer aided devices and platforms in ophthalmology drives the market of ophthalmology devices market. Lack of ophthalmologists, economic slowdown and saturation of the market in developed countries are the factors hampering the market growth.

North America accounts for the highest market share followed by Europe. Steep rise in aging population, increase in minimally invasive surgeries and favourable government policies makes U.S. the leader of ophthalmology devices market. However, Asian countries especially India and China are the fast growing regions with its growing demand for ophthalmology devices and increasing research investments.

This report would help the client in understanding the insights about market trends, dynamics, and in depth analysis of products/technologies, applications and other segments of Ophthalmology Devices global market. In addition, the research study also includes the future opportunities, technological advancements and competitive landscaping of major players in the Ophthalmology Devices industry.

The report provides an in depth market analysis of the above mentioned segments across the
following regions:

- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Carl Zeiss AG
  • Essilor International
  • Haag-Streit holdings AG
  • Hoya corporation
  • Johnson & Johnson
  • MORE


1 Executive summary

2 Introduction

2.1 Key Take-Aways
2.2 Report Description
2.3 Markets Covered
2.4 Stakeholders
2.5 Research Methodology
2.5.1 Market Size Estimation
2.5.2 Market Breakdown & Data Trangulation
2.5.3 Secondary Sources
2.5.4 Key Data Points from Secondary Sources
2.5.5 Primary Sources
2.5.6 Key Data Points from Primary Sources
2.5.7 Assumptions

3 Market Analysis

3.1 Introduction
3.2 Market Segmentation
3.3 Factors influencing market
3.3.1 Drivers & Opportunities
3.3.1.1 Increasing baby boomer population and incidence of degenerative diseases of eyes
3.3.1.2 Increase in R&D activities by ophthalmology key players
3.3.1.3 Extensive use of high-end technologies involving use of software and computer aided devices and platforms
3.3.1.4 Untapped emerging markets
3.3.1.5 Development of minimal invasive surgery
3.3.2 Restraints
3.3.2.1 Lack of ophthalmologists
3.3.2.2 Economic slowdown and saturation of the market in developed countries
3.3.2.3 Reimbursement cuts
3.3.3 Threats
3.3.3.1 Intensified competition
3.3.4 Challenges
3.3.4.1 Lack of insurance coverage in developing countries and insufficient coverage for IOLs in developed countries
3.3.4.2 Extended timelines of device approval
3.4 Regulatory affairs
3.4.1 U.S.
3.4.2 Europe
3.4.3 China
3.4.4 India
3.4.5 Japan
3.5 Reimbursement Scenario
3.5.1 Reimbursement table
3.6 Patent trends
3.7 Technology advancements
3.8 Upcoming technologies
3.9 Porter's Five Force Analysis
3.9.1 Threat of new entrants
3.9.2 Threat of substitutes
3.9.3 Rivalry among existing competitors
3.9.4 Bargaining power of suppliers
3.9.5 Bargaining power of buyers
3.10 Market share analysis by major players

4 Global Ophthalmology devices market, by products

4.1 Introduction
4.1.1 Global ophthalmology diagnostic devices by product types
4.1.1.1 Autorefractors
4.1.1.2 Slit lamp
4.1.1.3 Tonometer
4.1.1.4 Ophthalmoscope
4.1.1.5 Keratometer
4.1.1.6 Corneal topographer
4.1.1.7 Optical coherence tomography
4.1.1.8 Fundus camera
4.1.1.8.1 Non-mydriatic fundus cameras
4.1.1.8.2 Mydriatic fundus cameras
4.1.1.8.3 Hybrid fundus cameras
4.1.1.8.4 Retinopathy of prematurity (ROP)
4.1.1.9 Ophthalmic ultrasound imaging system
4.1.1.10 Retinoscope
4.1.1.11 Perimeter
4.1.1.12 Pachymeter
4.1.1.13 Others
4.1.1.13.1 Snellen chart
4.1.1.13.2 Amsler grid eye test
4.1.1.13.3 Wavefront aberrometer
4.1.1.13.4 Point of care devices
4.1.2 Global ophthalmic surgical devices market
4.1.2.1 Introduction
4.1.2.2 Cataract surgery devices
4.1.2.2.1 Intraocular lens (IOL)
4.1.2.2.2 Phacoemulsification
4.1.2.2.3 OVDS (Ophthalmic Viscosurgical Devices)
4.1.2.2.4 YAG laser
4.1.2.3 Glaucoma surgery devices
4.1.2.3.1 Glaucoma lasers
4.1.2.3.2 Glaucoma surgery
4.1.2.3.3 Glaucoma implants
4.1.2.3.4 Glaucoma systems
4.1.2.4 Refractive error surgical devices
4.1.2.4.1 Photorefractive keratectomy (PRK)
4.1.2.4.2 Laser assisted sub-epithelium keratomileusis (LASEK)
4.1.2.4.3 Laser assisted insitu keratomileusis (LASIK)
4.1.2.4.4 Femtosecond laser
4.1.2.4.5 Epi-LASIK
4.1.2.4.6 Phakic intraocular lens (PIOLs)
4.1.2.5 Vitreoretinal surgical devices
4.1.2.5.1 Vitrectomy
4.1.2.5.2 Photocoagulation
4.1.2.5.3 Illumination
4.1.3 Global vision care devices
4.1.3.1 Introduction
4.1.3.2 Spectacle lenses
4.1.3.3 Contact lenses

5 Ophthalmology devices global market, by applications

5.1 Introduction
5.2 Cataract
5.3 Glaucoma
5.4 Age related macular degeneration
5.5 Diabetic retinopathy (DR)
5.6 Others (Refractive errors, amblyopia, strabismus)

6 Ophthalmology devices global market, by end-users

6.1 Introduction
6.2 Hospitals
6.3 Academic & Research laboratories
6.4 Others

7 Regional Market Analysis

7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.4 Asia Pacific
7.5 Rest of the World

8 Company developments

8.1 Introduction
8.2 New product launches
8.3 Agreements, partnerships, collaborations & joint ventures
8.4 Approvals
8.5 Mergers & acquisitions

9 Major companies

9.1 Abbott Laboratories
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Key Developments
9.1.5 Business Strategy
9.1.6 SWOT Analysis
9.2 Carl Zeiss AG
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Key Developments
9.2.5 Business Strategy
9.2.6 SWOT Analysis
9.3 Essilor International
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Key Developments
9.3.5 Business Strategy
9.3.6 SWOT Analysis
9.4 Haag-Streit holdings AG
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Key Developments
9.4.5 Business Strategy
9.4.6 SWOT Analysis
9.5 Hoya corporation
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Key Developments
9.5.5 Business Strategy
9.5.6 SWOT Analysis
9.6 Johnson & Johnson
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Key Developments
9.6.5 Business Strategy
9.6.6 SWOT Analysis
9.7 Nidek Co., Ltd
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Key Developments
9.7.5 Business Strategy
9.7.6 SWOT Analysis
9.8 Novartis AG
9.8.1 Overview
9.8.2 Financials
9.8.3 Product Portfolio
9.8.4 Key Developments
9.8.5 Business Strategy
9.8.6 SWOT Analysis
9.9 STAAR surgical company
9.9.1 Overview
9.9.2 Financials
9.9.3 Product Portfolio
9.9.4 Key Developments
9.9.5 Business Strategy
9.9.6 SWOT Analysis
9.10 Topcon corporation
9.10.1 Overview
9.10.2 Financials
9.10.3 Product Portfolio
9.10.4 Key Developments
9.10.5 Business Strategy
9.10.6 SWOT Analysis
9.11 Valeant pharmaceuticals International Inc
9.11.1 Overview
9.11.2 Financials
9.11.3 Product Portfolio
9.11.4 Key Developments
9.11.5 Business Strategy
9.11.6 SWOT Analysis

List of Tables

TABLE 1
Ophthalmology devices global market revenue, by region, (2013-2021) ($MN)
TABLE 2
Ophthalmology devices global market revenue, by product type, (2013-2021) ($MN)
TABLE 3
Ophthalmology devices global market revenue, by applications, (2013-2021) ($MN)
TABLE 4
Ophthalmology devices global market revenue, by end-users, (2013-2021) ($MN)
TABLE 5
Ophthalmology devices global market revenue, by product type, (2013-2021) ($MN)
TABLE 6
Diagnostic devices global market revenue, by type, (2013-2021) ($MN)
TABLE 7
Autorefractometer global market revenue, by region, (2013-2021) ($MN)
TABLE 8
Slit lamp global market revenue, by region, (2013-2021) ($MN)
TABLE 9
Tonometers global market revenue, by region, (2013-2021) ($MN)
TABLE 10
Ophthalmoscope global market revenue, by region, (2013-2021) ($MN)
TABLE 11
Keratometer global market revenue, by region, (2013-2021) ($MN)
TABLE 12
Corneal topographer global market revenue, by region, (2013-2021) ($MN)
TABLE 13
Optical coherence tomography global market revenue, by region, (2013-2021) ($MN)
TABLE 14
Fundus camera global market revenue, by region, (2013-2021) ($MN)
TABLE 15
Fundus camera global market revenue, by type, (2013-2021) ($MN)
TABLE 16
Non-mydriatic fundus camera global market revenue, by region, (2013-2021) ($MN)
TABLE 17
Mydriatic fundus camera global market revenue, by region, (2013-2021) ($MN)
TABLE 18
Hybrid fundus camera global market revenue, by region, (2013-2021) ($MN)
TABLE 19
Retinopathy of prematurity global market revenue, by region, (2013-2021) ($MN)
TABLE 20
Ophthalmic ultrasound Imaging system global market revenue, by region, (2013-2021) ($MN)
TABLE 21
Retinoscope global market revenue, by region, (2013-2021) ($MN)
TABLE 22
Perimeter global market revenue, by region, (2013-2021) ($MN)
TABLE 23
Pachymeter global market revenue, by region, (2013-2021) ($MN)
TABLE 24
Others (Diagnostics) global market revenue, by region, (2013-2021) ($MN)
TABLE 25
Surgical devices global market revenue, by region, (2013-2021) ($MN)
TABLE 26
Surgical devices global market revenue, by type, (2013-2021) ($MN)
TABLE 27
Cataract surgical devices global market revenue, by type, (2013-2021) ($MN)
TABLE 28
Cataract surgery devices global market revenue, by region, (2013-2021) ($MN)
TABLE 29
IOL global market revenue, by region, (2013-2021) ($MN)
TABLE 30
Phacoemulsification global market revenue, by region, (2013-2021) ($MN)
TABLE 31
OVD global market revenue, by region, (2013-2021) ($MN)
TABLE 32
Glaucoma surgery devices global market revenue, by region, (2013-2021) ($MN)
TABLE 33
Refractive surgery devices global market revenue, by region, (2013-2021) ($MN)
TABLE 34
Vitreoretinal surgery devices global market revenue, by region, (2013-2021) ($MN)
TABLE 35
Vision care global market revenue, by region, (2013-2021) ($MN)
TABLE 36
Vision care global market revenue, by type, (2013-2021) ($MN)
TABLE 37
Spectacle lenses global market revenue, by region, (2013-2021) ($MN)
TABLE 38
Contact lenses global market revenue, by region, (2013-2021) ($MN)
TABLE 39
Ophthalmology devices global market revenue, by application, (2013-2021) ($MN)
TABLE 40
Cataract global market revenue, by region, (2013-2021) ($MN)
TABLE 41
Glaucoma global market revenue, by region, (2013-2021) ($MN)
TABLE 42
Age related macular degeneration market revenue, by region, (2013-2021) ($MN)
TABLE 43
Diabetic retinopathy global market revenue, by region, (2013-2021) ($MN)
TABLE 44
Others (applications) global market revenue, by region, (2013-2021) ($MN)
TABLE 45
Ophthalmology devices global market revenue, by end-users, (2013-2021) ($MN)
TABLE 46
Hospitals global market revenue, by region, (2013-2021) ($MN)
TABLE 47
Academics & research laboratories global market revenue, by region, (2013-2021) ($MN)
TABLE 48
Other end users global market revenue, by region, (2013-2021) ($MN)
TABLE 49
North American ophthalmology devices market revenue, by product type, (2013-2021) ($MN)
TABLE 50
North American diagnostic devices market revenue, by type, (2013-2021) ($MN)
TABLE 51
North American fundus cameras market revenue, by type, (2013-2021) ($MN)
TABLE 52
North American surgical devices market revenue, by type, (2013-2021) ($MN)
TABLE 53
North American cataract surgery devices market revenue, by type, (2013-2021) ($MN)
TABLE 54
North American vision care market revenue, by type, (2013-2021) ($MN)
TABLE 55
North American ophthalmology devices market revenue, by application, (2013-2021) ($MN)
TABLE 56
North American ophthalmology devices market revenue, by end-user, (2013-2021) ($MN)
TABLE 57
European ophthalmology devices market revenue, by type, (2013-2021) ($MN)
TABLE 58
European diagnostic devices market revenue, by type, (2013-2021) ($MN)
TABLE 59
European fundus cameras market revenue, by type, (2013-2021) ($MN)
TABLE 60
European surgical devices market revenue, by type, (2013-2021) ($MN)
TABLE 61
European cataract surgery devices market revenue, by type, (2013-2021) ($MN)
TABLE 62
European vision care market revenue, by type, (2013-2021) ($MN)
TABLE 63
European ophthalmology devices market revenue, by application, (2013-2021) ($MN)
TABLE 64
European ophthalmology devices market revenue, by end-users, (2013-2021) ($MN)
TABLE 65
Asia-pacific ophthalmology devices market revenue, by type, (2013-2021) ($MN)
TABLE 66
Asia-pacific diagnostic devices market revenue, by type, (2013-2021) ($MN)
TABLE 67
Asia-pacific fundus cameras market revenue, by type, (2013-2021) ($MN)
TABLE 68
Asia-pacific surgical devices market revenue, by type, (2013-2021) ($MN)
TABLE 69
Asia-pacific cataract surgery devices market revenue, by type, (2013-2021) ($MN)
TABLE 70
Asia-pacific vision care market revenue, by type, (2013-2021) ($MN)
TABLE 71
Asia-pacific ophthalmology devices market revenue, by application, (2013-2021) ($MN)
TABLE 72
Asia-pacific ophthalmology devices market revenue, by end-users, (2013-2021) ($MN)
TABLE 73
RoW ophthalmology devices market revenue, by type, (2013-2021) ($MN)
TABLE 74
RoW diagnostics devices market revenue, by types, (2013-2021) ($MN)
TABLE 75
RoW fundus cameras market revenue, by type, (2013-2021) ($MN)
TABLE 76
RoW surgical devices market revenue, by type, (2013-2021) ($MN)
TABLE 77
RoW cataract surgery devices market revenue, by type, (2013-2021) ($MN)
TABLE 78
RoW vision care market revenue, by type, (2013-2021) ($MN)
TABLE 79
RoW ophthalmology devices market revenue, by application, (2013-2021) ($MN)
TABLE 80
RoW ophthalmology devices market revenue, by end-users, (2013-2021) ($MN)
TABLE 81
New product launches (2013-2015)
TABLE 82
Agreements, partnership, collaboration & joint ventures (2013-2015)
TABLE 83
Approvals (2013-2015)
TABLE 84
Mergers & acquisitions (2013-2015)
TABLE 85
Abbott laboratories: total revenue and R&D expenses, (2012-2014) ($MN)
TABLE 86
Abbott laboratories: total revenue, by segments, (2012-2014) ($MN)
TABLE 87
Abbott laboratories: revenue segments of medical devices, (2013-2014)($MN)
TABLE 88
Abbott laboratories: total revenue, by geography, (2012-2014) ($MN)
TABLE 89
Carl Zeiss AG: total sales and R&D expenses (2012-2014) ($MN)
TABLE 90
Carl Zeiss: total sales, by segments, (2012-2014) ($MN)
TABLE 91
Carl Zeiss: total sales, by geography, (2012-2014) ($MN)
TABLE 92
Essilor: total revenue and R&D expenses, (2012-2014) ($MN)
TABLE 93
Essilor international: total revenue, by segments, (2012-2014) ($MN)
TABLE 94
Essilor international: total revenue, by geography, (2012-2014) ($MN)
TABLE 95
Hoya corporation: total revenue and R&D expenses (2012-2014) ($MN)
TABLE 96
Hoya corporation: total revenue, by segments, (2012-2014) ($MN)
TABLE 97
Hoya corporation: total revenue, by geography, (2012-2014) ($MN)
TABLE 98
Johnson & Johnson: total revenue and R&D expenses (2012-2014) ($MN)
TABLE 99
Johnson & Johnson: total revenue, by segments, (2012-2014) ($MN)
TABLE 100
Johnson & Johnson: total revenue, by geography, (2012-2014) ($MN)
TABLE 101
Novartis: total revenue and R&D expenses, (2012-2014) ($MN)
TABLE 102
Novartis AG: total revenue, by segments, (2012-2014) ($MN)
TABLE 103
Novartis AG: segmental revenue of Alcon laboratories, (2012-2014) ($MN)
TABLE 104
Novartis AG: total revenue, by geography, (2012-2014) ($MN)
TABLE 105
Staar surgical company: total revenue and R&D expenses, (2012-2014) ($MN)
TABLE 106
Staar surgical company: total revenue, by segments, (2012-2014) ($MN)
TABLE 107
Staar surgical company: total revenue, by geography (2012-2014) ($MN)
TABLE 108
Topcon Corporation.: total sales and R&D expenses (2012-2014) ($MN)
TABLE 109
Topcon corporation: total sales, by segments, (2012-2014) ($MN)
TABLE 110
Topcon corporation: total sales, by geography, (2012-2014) ($MN)
TABLE 111
Valeant pharmaceutical international, inc: total revenue and R&D expenses, (2012-2014) ($MN)
TABLE 112
Valeant pharmaceutical international, inc: total revenue, by segments, (2012-2014) ($MN)
TABLE 113
Valeant pharmaceutical international, inc: total revenue, by geography, (2012-2014) ($MN)

List of Figures

FIGURE 1
Global ophthalmology devices market share and revenue, by region (2013-2021)
FIGURE 2
Research methodology: ophthalmology devices global market
FIGURE 3
Ophthalmology devices market: top-down and bottom-up approach
FIGURE 4
Ophthalmology devices market: forecasting model
FIGURE 5
Ophthalmology devices market: market breakdown & data triangulation
FIGURE 6
Ophthalmology devices market segmentation
FIGURE 7
Market dynamics
FIGURE 8
Ophthalmology devices market: patent filing by major players (2010-2015)
FIGURE 9
Ophthalmology devices market: patent filing by segment, (2010-2015)
FIGURE 10
Ophthalmology devices market: porter’s analysis
FIGURE 11
Ophthalmology devices global market share analysis, by key players, 2014
FIGURE 12
Ophthalmology devices global market revenue, by type, (2014 v’s 2021) ($MN)
FIGURE 13
Global ophthalmology device market revenue, by surgery (2014 v’s 2021) ($MN)
FIGURE 14
Ophthalmology devices global market revenue, by application (2014 v’s 2021) ($MN)
FIGURE 15
Ophthalmology devices global market revenue, by end users (2013 v’s 2021) ($MN)
FIGURE 16
Global ophthalmology devices market revenue, by region (2013-2021) ($MN)
FIGURE 17
North American ophthalmology devices market size, by product type, application & end-user outlook, (2014 v’s 2021)
FIGURE 18
European ophthalmology market size, by product type, application & end-user outlook, (2014 v’s 2021)
FIGURE 19
Asia-pacific Ophthalmology devices market size, by type, product, application & end-user outlook, (2014 v’s 2021)
FIGURE 20
Row ophthalmology devices market size, by type, product, application & end-user outlook, (2014 v’s 2021)
FIGURE 21
Key growth strategies, (2013-2015)
FIGURE 22
SWOT: Abbott laboratories
FIGURE 23
SWOT: Carl Zeiss
FIGURE 24
SWOT: Essilor international
FIGURE 25
SWOT: Haag-Streit AG
FIGURE 26
SWOT: Hoya Corporation
FIGURE 27
SWOT: Johnson & Johnson
FIGURE 28
SWOT: Novartis AG
FIGURE 29
SWOT: STAAR surgical company
FIGURE 30
SWOT: Topcon Corporation
FIGURE 31
SWOT: Valeant Pharmaceuticals International

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Abbott Laboratories
- Carl Zeiss AG
- Essilor International
- Haag-Streit holdings AG
- Hoya corporation
- Johnson & Johnson
- Nidek Co., Ltd
- Novartis AG
- STAAR surgical company
- Topcon corporation
- Valeant pharmaceuticals International Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll